CASIRIVIMAB

UNII: J0FI6WE1QN
Preferred Substance Name: CASIRIVIMAB

2415933-42-3
CASIRIVIMAB [INN]
CASIRIVIMAB [JAN]
CASIRIVIMAB [USAN]
CASIRIVIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10933 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10933 .KAPPA.-CHAIN, DIMER
REGN10933
REGN-10933

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CASIRIVIMAB

Synonyms and Mappings

Resources

Note